Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).
about
Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysisThe Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells.Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis.Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma.Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysisFrom big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma.Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancerHepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways.Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde.Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgeryCyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival.Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.Discovery of a novel anti-cancer agent targeting both topoisomerase I and II in hepatocellular carcinoma Hep 3B cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde.Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinoma.Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.miR-203 inhibits proliferation of HCC cells by targeting survivin.The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
P2860
Q28067391-EC600D22-1209-452F-9C7A-2528E3021CE0Q33612421-4B9C84A3-93CB-4B19-8189-C5A9C2C30815Q33988315-8D5C4BBB-813E-4F67-9625-E76A405C9EE4Q34427388-F971CAA2-5ABD-4B94-B599-9996305BDC16Q35080302-67E7AF63-E0A7-458B-8CDC-4D8F86C2724CQ35119245-FC21845D-2BF9-49BA-BBE3-499F888478ADQ36313998-1EEAF77B-D36A-4AD5-A539-05DB37CFA82DQ36367559-E0F4CAB7-7082-4B20-87CD-44831E3BD1CBQ36397362-1330E886-D47A-40CA-AD7E-75BB842E395AQ36451713-F9657A9F-1356-4F65-A72E-7CBCF039EEA2Q36734211-BEDF9C86-1826-4DD6-971B-B755FCEF4C0BQ37359625-56284943-B1EF-4E03-8B3B-917CE4C26245Q39001620-1A53C61F-8EF6-4533-AFCE-53C1F17DE55DQ40168060-24A00C13-1046-4278-8F74-857ADE1BD8B9Q41126912-A981AA42-39C2-4076-8CC5-EB05C99D2D8BQ43704191-9BAF28B2-85F4-49CD-8F47-FE8292F0BDC8Q44740285-85E6D999-7277-479C-9271-8C39BD424F10Q51093729-79772C17-4445-4827-9C36-CCCC7F0E8996
P2860
Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC).
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Clinical significance of Cox-2 ...... epatocellular carcinoma (HCC).
@en
Clinical significance of Cox-2 ...... epatocellular carcinoma (HCC).
@nl
type
label
Clinical significance of Cox-2 ...... epatocellular carcinoma (HCC).
@en
Clinical significance of Cox-2 ...... epatocellular carcinoma (HCC).
@nl
prefLabel
Clinical significance of Cox-2 ...... epatocellular carcinoma (HCC).
@en
Clinical significance of Cox-2 ...... epatocellular carcinoma (HCC).
@nl
P2093
P2860
P1433
P1476
Clinical significance of Cox-2 ...... epatocellular carcinoma (HCC).
@en
P2093
P2860
P2888
P304
P356
10.1007/S12032-010-9519-Y
P577
2010-04-17T00:00:00Z